Licensing, acquisitions, and strategic investment in cardiometabolic disease and oncology.

Securities offered through IIB Corp, (member FINRA, SIPC)

IMS Health has established a small, boutique, life-science focused investment banking subsidiary called IMS Health Capital, Inc. (member FINRA, SIPC)Our offerings and licenses permit us to advise on M&A, licensing, partnering, and private financing transactions. Given our unique positioning and access to a vast array of information and relationships, we see a high volume of opportunities. We are excited to be up and running and look forward to further strengthening our relationships.

Life science strategy consulting:Comprehensive suite of consulting services tailored to supporting small and mid-sized companies exploring partnering or financing opportunitiesExpertise in global pricing and reimbursement to support product development strategy, inform portfolio planning, and augment business development decisions

Lead project teams as a trusted advisor to large and small biopharmaceutical companies, focusing on strategy development in business development and pricing & market access.Business development strategy consulting:- In-licensing and out-licensing valuation support through rapid assessment of payer views on pricing and market access and price/access-adjusted physician utilization expectations- Longer engagements with out-licensors to develop and refine the commercial story for an asset through assessment of P&MA opportunities and challenges, and development of robust and credible valuation models- Deal flow support including develpment of a partnering strategy, outreach to potential partners, and deal process supportPricing and Market Access consulting:- Expertise across numerous therapeutic areas in projects spanning the entire product lifecycle- Employment of methodologies and approaches acquired through work at two of the leading global pricing and market access consultancies

Application of accumulated knowledge in discovery research, clinical development and marketing strategy to support the successful commercialization of life sciences products from conception through loss of exclusivity.-- Draw from experience across a broad range of therapeutic areas including hematology, neurology, respiratory, diabetes, vaccines and oncology-- Employ qualitative and quantitative methodologies to derive optimal solutions-- Develop actionable recommendations to support clinical trial design, value messaging, product positioning, launch planning, environmental assessment, asset valuation and due diligence in licensing transactions-- Build models to synthesize primary and secondary research findings

Gene-therapy based translational research within a hybrid research/clinical laboratory setting. -- vector design -- vector delivery -- immunologic barriers to vector delivery -- translational team

Program evaluation for a billion dollar congressional initiative to develop the nation's biodefense research infrastructure -- milestones and metrics -- dynamic funding and prioritization strategies -- basic and translational research alignment